Medicus Pharma Ltd (NASDAQ: MDCX) on Tuesday, plunged -12.06% from the previous trading day, before settling in for the closing price of $3.4. Within the past 52 weeks, MDCX’s price has moved between $1.80 and $8.94.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 5.17%. With a float of $2.34 million, this company’s outstanding shares have now reached $13.42 million.
The extent of productivity of a business whose workforce counts for 12 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Medicus Pharma Ltd (MDCX) Insider Updates
Observing investor behavior towards Drug Manufacturers – General industry stocks is more important than anything else. The insider ownership of Medicus Pharma Ltd is 80.22%, while institutional ownership is 25.85%. The most recent insider transaction that took place on May 20 ’25, was worth 578,940. In this transaction 10% Owner of this company sold 75,000 shares at a rate of $7.72, taking the stock ownership to the 3,248,741 shares. Before that another transaction happened on May 20 ’25, when Company’s Major Shareholders proposed sale 118,000 for $195.49, making the entire transaction worth $23,067,500.
Medicus Pharma Ltd (MDCX) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 5.17% per share during the next fiscal year.
Medicus Pharma Ltd (NASDAQ: MDCX) Trading Performance Indicators
Medicus Pharma Ltd (MDCX) is currently performing well based on its current performance indicators. A quick ratio of 1.53 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.43, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -0.91 in one year’s time.
Technical Analysis of Medicus Pharma Ltd (MDCX)
The latest stats from [Medicus Pharma Ltd, MDCX] show that its last 5-days average volume of 0.57 million was superior to 0.17 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 69.90%.
During the past 100 days, Medicus Pharma Ltd’s (MDCX) raw stochastic average was set at 10.66%, which indicates a significant decrease from 50.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.37 in the past 14 days, which was lower than the 0.58 volatility it showed in the past 100 days.
Now, the first resistance to watch is $3.49. This is followed by the second major resistance level at $3.98. The third major resistance level sits at $4.28. If the price goes on to break the first support level at $2.70, it is likely to go to the next support level at $2.40. Assuming the price breaks the second support level, the third support level stands at $1.91.
Medicus Pharma Ltd (NASDAQ: MDCX) Key Stats
Market capitalization of the company is 47.64 million based on 13,573K outstanding shares. Right now, sales total 0 K and income totals -11,160 K. The company made 0 K in profit during its latest quarter, and -5,100 K in sales during its previous quarter.
